Clinical validation of Trop-2 as a serum biomarker for monitoring of disease-course in patients affected by breast and colon cancer

Project Information

ThruBlood

Grant agreement ID: 719856

DOI 10.3030/719856

Project closed

EC signature date 22 February 2016

Start date 1 March 2016

End date 31 August 2016

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost € 71 429,00

EU contribution € 50 000,00

Coordinated by

ONCOXX BIOTECH SRL
Italy